TickerFactsScreenerDevelopers

Intellia Therapeutics, Inc. (NTLA) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2016: $36.11M2017: -$65.28M2018: -$61.26M2019: -$103.24M2020: -$49.91M2021: -$225.03M2022: -$333.29M2023: -$394.09M2024: -$348.88M2025: -$394.74M-$394.74M
2016Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$394.74M-13.1%
2024-$348.88M+11.5%
2023-$394.09M-18.2%
2022-$333.29M-48.1%
2021-$225.03M-350.9%
2020-$49.91M+51.7%
2019-$103.24M-68.5%
2018-$61.26M+6.2%
2017-$65.28M-280.8%
2016$36.11M—